<![CDATA[Genmab — Januar 2025]]>Godt nytår ! Måske er det så enkelt som beskrevet her ? https://x.com/BourbonCap/status/1874455819430850839

]]>https://dev.proinvestor.com/forum/topic/399192/genmab-januar-2025RSS for NodeSun, 07 Jun 2026 06:31:16 GMTWed, 01 Jan 2025 14:58:06 GMT60<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 20:34:21 GMT]]>EL, you had couple of days ago a link to a conference/seminar on hexa….slmething in March. Cant find your link :-), please

]]>https://dev.proinvestor.com/forum/post/7681876https://dev.proinvestor.com/forum/post/7681876Fri, 31 Jan 2025 20:34:21 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 19:41:04 GMT]]>some extra attention to this article with focus on hexamerization in anticipation of.....

]]>https://dev.proinvestor.com/forum/post/7681877https://dev.proinvestor.com/forum/post/7681877Fri, 31 Jan 2025 19:41:04 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 19:39:42 GMT]]>Genmab
@Genmab
Genmab and academia partners are proud to share a review in Seminars in Immunology on optimizing antibody therapies through enhanced complement activation.
https://x.com/Genmab/status/1885415198938296560

]]>https://dev.proinvestor.com/forum/post/7681874https://dev.proinvestor.com/forum/post/7681874Fri, 31 Jan 2025 19:39:42 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 12:02:39 GMT]]>Som en sidebemærkning er Genmab nr 8 blandt de 50 største selskabskatteydere i 2023 med 1,273 mia. kr. Størst er selvfølgelig Novo Holding med knap 15,3 mia. kr https://borsen.dk/nyheder/virksomheder/sky-energimilliardaer-og-nordjysk-storfisker-stryger-frem-pa-skatteliste?b_source=borsen&b_medium=row_0&b_campaign=news_2

]]>https://dev.proinvestor.com/forum/post/7681873https://dev.proinvestor.com/forum/post/7681873Fri, 31 Jan 2025 12:02:39 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 11:44:24 GMT]]>; Epkinly U.S. revenues reflect profit sharing. International revenues reflect product revenues as well as profit sharing from certain international territories. > so lets estimate
we end up around $280mn for 2024 total vs Roch ~$267mn

]]>https://dev.proinvestor.com/forum/post/7681875https://dev.proinvestor.com/forum/post/7681875Fri, 31 Jan 2025 11:44:24 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 11:42:40 GMT]]>so that's a flat quarter, similar to Roche, was also flattish

]]>https://dev.proinvestor.com/forum/post/7681869https://dev.proinvestor.com/forum/post/7681869Fri, 31 Jan 2025 11:42:40 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 11:41:54 GMT]]>ABBVIE Epkinly Q4 '24 US 18 Intl 22 Tot 40 , Full year 60

86

146

]]>https://dev.proinvestor.com/forum/post/7681867https://dev.proinvestor.com/forum/post/7681867Fri, 31 Jan 2025 11:41:54 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 11:38:36 GMT]]>Så kom der da 2 gode nyheder, og Genmab stiger fantastiske 0,5%….det er da flot 🙂

]]>https://dev.proinvestor.com/forum/post/7681870https://dev.proinvestor.com/forum/post/7681870Fri, 31 Jan 2025 11:38:36 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 10:49:31 GMT]]>Genmab får potentiel godkendelse af kræftmidlet Tivdak af europæiske sundhedsmyndigheder https://proinvestor.com/investornyt/1271975/genmab-far-potentiel-godkendelse-af-kraeftmidlet-tivdak-af-europaeiske-sundhedsmyndigheder

]]>https://dev.proinvestor.com/forum/post/7681871https://dev.proinvestor.com/forum/post/7681871Fri, 31 Jan 2025 10:49:31 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 10:28:33 GMT]]>Med godkendelsen er vejen mere eller mindre banet for en endelig godkendelse. Beslutningen om en endelig markedsføringsgodkendelse skal træffes af EU-Kommissionen, som normalt følger indstillingen fra komitéen.

Tivdak markedsføres i forvejen i USA som behandling af tilbagevendende eller metastatisk livmoderhalskræft. Tivdak går også under navnet Tisotumab Vedotin."

]]>https://dev.proinvestor.com/forum/post/7681872https://dev.proinvestor.com/forum/post/7681872Fri, 31 Jan 2025 10:28:33 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 10:28:09 GMT]]>Fra MW" Der ser ud til, at kræftmidlet Tivdak, som Genmab står bag sammen med partneren Pfizer, kan blive markedsført i Europa til behandling af tilbagevendende eller metastatisk livmoderhalskræft.

Ifølge de europæiske sundhedsmyndigheder, EMA, er det komitéen for humanmedicinske lægemidler (CHMP), der har nikket ja.

  • Fordelene ved Tivdak er dets overlegenhed med hensyn til at forlænge overlevelsen og overlevelsen uden sygdomsprogression sammenlignet med kemoterapi, skriver EMA i meddelelsen.
]]>https://dev.proinvestor.com/forum/post/7681864https://dev.proinvestor.com/forum/post/7681864Fri, 31 Jan 2025 10:28:09 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 10:10:03 GMT]]>
Link Preview Image
Tivdak | European Medicines Agency (EMA)

favicon

European Medicines Agency (EMA) (www.ema.europa.eu)

]]>https://dev.proinvestor.com/forum/post/7681863https://dev.proinvestor.com/forum/post/7681863Fri, 31 Jan 2025 10:10:03 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 10:09:06 GMT]]>!! Tivdak (tisotumab vedotin) received a positive opinion from the CHMP for the treatment of recurrent or metastatic cervical cancer. !! https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2025

]]>https://dev.proinvestor.com/forum/post/7681868https://dev.proinvestor.com/forum/post/7681868Fri, 31 Jan 2025 10:09:06 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 09:50:27 GMT]]>Servicemeddelelse: Beklager enkelte udfald på sitet. Vi er ved at konfigurere vores firewalls efter hidsige hackerangreb de seneste dage. Hoveddelen af dette arbejde prøver vi at færdiggøre lørdag. Mvh Helge

]]>https://dev.proinvestor.com/forum/post/7681866https://dev.proinvestor.com/forum/post/7681866Fri, 31 Jan 2025 09:50:27 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 09:26:21 GMT]]>'
Stor salgsvækst for Genmabs sklerosemiddel styrker topsalgsforhåbninger, mener Genmab https://proinvestor.com/investornyt/1271898/stor-salgsvaekst-for-genmabs-sklerosemiddel-styrker-topsalgsforhabninger-mener-genmab

]]>https://dev.proinvestor.com/forum/post/7681858https://dev.proinvestor.com/forum/post/7681858Fri, 31 Jan 2025 09:26:21 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 08:06:39 GMT]]>For the Dutch viewers - Dr. Marcel Nijland over epcoritamab bij folliculaire lymfomen https://www.mednet.nl/congres-nieuws/dr-marcel-nijland-over-epcoritamab-bij-folliculaire-lymfomen/

]]>https://dev.proinvestor.com/forum/post/7681861https://dev.proinvestor.com/forum/post/7681861Fri, 31 Jan 2025 08:06:39 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 07:30:37 GMT]]>Sydbank må være ude med en analyse for der er mange flash nu fx "GENMAB/SYDBANK: MEN I FORHOLD TIL AKTIEN ER DER EKSTREMT MEGET FOKUS PÅ HEXABODY CD38-DATA"

]]>https://dev.proinvestor.com/forum/post/7681856https://dev.proinvestor.com/forum/post/7681856Fri, 31 Jan 2025 07:30:37 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 07:13:20 GMT]]>God formiddag. 🙂

]]>https://dev.proinvestor.com/forum/post/7681859https://dev.proinvestor.com/forum/post/7681859Fri, 31 Jan 2025 07:13:20 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 07:09:47 GMT]]>hahaha... This is the end, Beautiful friend, This is the end, My only friend, the end 😉

]]>https://dev.proinvestor.com/forum/post/7681865https://dev.proinvestor.com/forum/post/7681865Fri, 31 Jan 2025 07:09:47 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 07:07:27 GMT]]>Det er for tidligt tilsarkasme Gentogen 🙂

]]>https://dev.proinvestor.com/forum/post/7681862https://dev.proinvestor.com/forum/post/7681862Fri, 31 Jan 2025 07:07:27 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 06:54:05 GMT]]>Nej. For jo mere de tjener nu, jo mindre vil den engang i fremtiden ikke tjene mere. Så alt godt ny er på sigt dårligt......

]]>https://dev.proinvestor.com/forum/post/7681853https://dev.proinvestor.com/forum/post/7681853Fri, 31 Jan 2025 06:54:05 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 06:52:32 GMT]]>Vi skal da stige i dag..

]]>https://dev.proinvestor.com/forum/post/7681855https://dev.proinvestor.com/forum/post/7681855Fri, 31 Jan 2025 06:52:32 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 06:49:34 GMT]]>Og gode nyheder….

]]>https://dev.proinvestor.com/forum/post/7681850https://dev.proinvestor.com/forum/post/7681850Fri, 31 Jan 2025 06:49:34 GMT<![CDATA[Reply to Genmab — Januar 2025 on Fri, 31 Jan 2025 06:49:09 GMT]]>Plejer kursen ikke at vende snuden nedad ved dårlige nyheder …

]]>https://dev.proinvestor.com/forum/post/7681854https://dev.proinvestor.com/forum/post/7681854Fri, 31 Jan 2025 06:49:09 GMT